Work

A Novel Nomogram for Predicting Rebleeding in Patients with Acute Non-variceal Upper Gastrointestinal Bleeding: A Retrospective Cohort Study

Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Rebleeding remains a substantial complication in patients with acute non-variceal upper gastrointestinal bleeding (ANVUGIB), often leading to extended hospitalization and adverse outcomes. This study aimed at developing a clinically useful predictive model for identifying ANVUGIB patients with an increased risk of rebleeding. This retrospective study included 638 patients diagnosed with ANVUGIB at the Central Hospital of Wuhan between January 2016 and December 2020. Data on patient demographics, hemodynamic parameters, clinical characteristics, and factors potentially influencing rebleeding were collected. Predictor variables were identified using least absolute shrinkage and selection operator (LASSO) regression, followed by multivariable logistic regression to develop a nomogram for predicting in-hospital rebleeding. The model's discriminative ability was evaluated using the area under the receiver operating characteristic curve (AUROC). Calibration plots were utilized to assess model calibration. Internal validation was performed through bootstrap resampling, and the clinical utility of the nomogram was examined using decision curve analysis(DCA). The DeLong test was employed to statistically assess the differences in discriminatory ability between the proposed model and established prognostic tools, including the AIMS65, Glasgow-Blatchford score, and Rockall score. The study included 638 ANVUGIB patients, with 61(9.6%) experienced rebleeding during their hospitalization. A prediction model was constructed based on three predictors of rebleeding: serum albumin levels, endoscopic risk classification, and the American Society of Anesthesiologists (ASA) score. The model exhibited excellent discrimination performance with an AUROC of 0.870 (95% confidence interval: 0.820–0.921). The calibration curve indicated good consistency between predicted and observed rebleeding events. The calibration-in-the-large value was 0.001, with a calibration slope of 0.994. DCA suggested that the nomogram offered considerable clinical net benefit across a threshold probability range of 2% to 70%. Furthermore, the new nomogram demonstrated significantly superior discrimination compared to established scoring systems. To sum up, the novel model exhibited robust predictive performance for rebleeding risk among patients with ANVUGIB, providing a reliable tool to assist clinical decision-making.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7234015365
Cites: 49
Cited by:
Related to: 10